Recombinant DNA Advisory Committee - 10/16/90 
during the fall. He noted that the RAC had evolved over the 
years in their outlook towards oversight in relation to that of 
the regulatory agencies and asked if the EDF had participated in 
any of the regional hearings. 
Dr. Goldburg noted that she had testified on behalf of the EDF in 
the regional hearing in New York City and had submitted written 
testimony at that time. Dr. Schaechter said he would re-read 
that testimony with interest with a view toward these issues. 
Dr. Schaechter noted that the subcommittee had disagreed with the 
second objection of the EDF relative to environmental release in 
that the NIH Guidelines are clear on the issue of the 
applicability of Government regulation. Dr. Goldburg said that 
the provisions of the Resource and Recovery Act had never been 
implemented by ERA to cover infectious waste and that this was a 
point of specific concern to the EDF. She said, "You can put 
just about anything down the drain you want." Dr. Schaechter 
asked for a response from ERA on this point. 
Dr. McGarrity reminded the committee that there was a motion on 
the table made by Dr. Riley. Dr. McGarrity asked that the motion 
be restated. 
Dr. Wivel and Dr. McGarrity discussed the actual motion with the 
attempt to clarify exactly what revisions to the Appendix were 
being considered, if any. Dr. Wivel said his view was that Dr. 
Riley moved acceptance of Appendix K with the modifications 
suggested, with the proviso that staff assure consistency between 
the tabular presentation and the prose. The staff will provide a 
revised document to the subcommittee for Revision of the NIH 
Guidelines prior to consideration by the entire RAC. 
Dr. McGarrity put the motion to a vote. The motion passed by a 
vote of 20 in favor, none opposed and no abstentions. 
Dr. Krogstad suggested that Dr. Milewski be in attendance at the 
next meeting of the subcommittee for Revision of the NIH 
Guidelines to act as a consultant on issues of ERA regulatory 
oversight. Dr. McGarrity added that if any other members of the 
committee had concerns or suggestions that they be conveyed to 
the Chair and he would pass them on to staff. 
At this point. Dr. McGarrity called for a brief recess and asked 
that the RAC reassemble at 10:47 a.m. 
Dr. McGarrity reconvened the RAC at 11:00 a.m., and noted that 
the next item on the agenda would be a discussion of a 
[346] 
Recombinant DNA Research, Volume 14 
